PHAN CHAU TRINH UNIVERSITY
PHAN CHAU TRINH UNIVERSITY
Tuyển Sinh Đại Học
Admissions 2025
Connect with us on Zalo:
0962 553 155 - 0981 559 255

Contact Admission

Email Us:
Call Us:
+84 0981 559 255
Send your documents:
09 Nguyen Gia Thieu Street, Dien Ngoc Ward, Dien Ban Town, Quang Nam Province, Vietnam
Follow Us on Social Media
Follow us on social media for tips, news and updates about appling to Phan Chau Trinh University:

JAMA Dermatology

Trouble viewing this email? Read it Online
 JAMA Dermatology Online First: Read new online first articles from JAMA Dermatology, a publication of the JAMA Network. Advertisement
JAMA Dermatology masthead

Online First

 JULY 19, 2023
facebook icon twitter icon linked in icon pinterest icon youtube icon instagram icon

ORIGINAL INVESTIGATION

Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression

Petter Gjersvik, MD, PhD; Ragnhild S. Falk, PhD; Ingrid Roscher, MD; et al.

BRIEF REPORT

Incidence and Prevalence of Diagnosed Vitiligo According to Race and Ethnicity, Age, and Sex in the US

Nicole Mastacouris, MS; Andrew Strunk, MA; Amit Garg, MD

Editor's Note: Strengths and Limitations of Study Designs Using Administrative Data to Assess Incidence and Prevalence of Disease ; John S. Barbieri, MD, MBA

Self-Help Habit Replacement in Individuals With Body-Focused Repetitive Behaviors: A Proof-of-Concept Randomized Clinical Trial

Steffen Moritz, PhD; Danielle Penney, BA; Franziska Missmann, MSc; et al.

EDITOR'S NOTE

Strengths and Limitations of Study Designs Using Administrative Data to Assess Incidence and Prevalence of Disease

John S. Barbieri, MD, MBA

OBSERVATION

Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab

Yuta Koike, MD, PhD; Takuya Takeichi, MD, PhD; Norito Ishii, MD, PhD; et al.

CORRECTION

Errors in Figure 2 and Table 2 Footnotes

TRENDING NOW ON JAMA DERMATOLOGY

Vulvar Lichen Sclerosus

Hydroa Vacciniforme

Sarcoidosis of the Skin

Exploring Discordance Between Patients and Clinicians—Understanding Perceived Disease Severity

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

Be part of the story. Follow JAMA Network on Instagram.
JAMA Network signature

Thank you for subscribing to JAMA Network email alerts. This message was sent to buiduytam1@gmail.com by updates@jamanetwork.org.

To update your contact information, change your email preferences, or unsubscribe, click here.

To ensure you always receive JAMA Network emails, add the email address updates@jamanetwork.org to your address book.

To unsubscribe by mail, contact:

JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.
facebook icon twitter icon linked in icon pinterest icon youtube icon instagram icon

©2023 American Medical Association. All rights reserved.

Other library

PCTU pctu Hội nghị khoa học